Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Surg Res ; 97(1): 97-102, 2001 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-11319888

RESUMEN

BACKGROUND: Clostridium difficile toxins alter permeability in cultured enterocytes and may alter intestinal epithelial permeability to bacteria in vivo. Experiments were designed to test the effects of C. difficile toxins on in vitro interactions of Enterococcus gallinarum with cultured enterocytes, as well as on translocation of E. gallinarum in mice. MATERIALS AND METHODS: Mature Caco-2 and HT-29 enterocytes were pretreated with C. difficile toxin A or toxin B followed by incubation with E. gallinarum. E. gallinarum-enterocyte interactions were assessed by quantitative culture. For in vivo experiments, antibiotic-treated mice were orally inoculated with C. difficile or saline, and all mice were orally inoculated 24 h later with E. gallinarum and sacrificed after another 24 h for analysis of cecal bacteria, cecal C. difficile toxin, and enterococcal translocation. Cecal C. difficile toxin was assayed as cytopathic effects on human foreskin fibroblasts. RESULTS: Although neither toxin had a noticeable effect on bacterial internalization by cultured enterocytes, C. difficile toxins were associated with increased E. gallinarum transmigration across confluent enterocyte cultures. Mice orally inoculated with saline rather than C. difficile (n = 29) had no detectable cecal toxin, while mice orally inoculated with C. difficile (n = 30) had detectable cecal toxin. Viable E. gallinarum was recovered from the mesenteric lymph nodes of 97% of mice orally inoculated with saline followed by oral E. gallinarum, but only 37% of mice orally inoculated with C. difficile followed by oral E. gallinarum (P < 0.01). CONCLUSIONS: These results suggested that observations with cultured enterocytes, demonstrating that C. difficile toxins facilitated bacterial migration across the intestinal epithelium, might have little in vivo relevance in a mouse model of antibiotic-induced C. difficile overgrowth.


Asunto(s)
Proteínas Bacterianas , Toxinas Bacterianas/farmacología , Traslocación Bacteriana , Enterococcus/fisiología , Enterotoxinas/farmacología , Animales , Antibacterianos/farmacocinética , Antibacterianos/farmacología , Toxinas Bacterianas/análisis , Ciego/microbiología , Línea Celular , Permeabilidad de la Membrana Celular , Clostridioides difficile/patogenicidad , Enterocitos/efectos de los fármacos , Enterocitos/metabolismo , Enterocitos/microbiología , Enterotoxinas/análisis , Femenino , Gentamicinas/farmacocinética , Gentamicinas/farmacología , Humanos , Mucosa Intestinal/metabolismo , Intestinos/anatomía & histología , Ganglios Linfáticos/microbiología , Mesenterio , Ratones
2.
Clin Diagn Lab Immunol ; 8(1): 192-5, 2001 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11139219

RESUMEN

Antibiotic-treated mice orally inoculated with one of three Candida albicans strains (including two mutant strains) or indigenous Candida pelliculosa showed levels of candidal gastrointestinal colonization that were strain specific. However, regardless of strain, the numbers of viable candida were intermediate to high in the stomach, were consistently lowest in the upper small intestine, and increased progressively down the intestinal tract.


Asunto(s)
Candidiasis/microbiología , Sistema Digestivo/microbiología , Mutación , Animales , Antibacterianos/administración & dosificación , Antibacterianos/uso terapéutico , Bacitracina/administración & dosificación , Bacitracina/uso terapéutico , Candida albicans/enzimología , Candida albicans/genética , Candida albicans/fisiología , Candidiasis/patología , Modelos Animales de Enfermedad , Femenino , Proteínas Fúngicas/genética , Proteínas Fúngicas/metabolismo , Gentamicinas/administración & dosificación , Gentamicinas/uso terapéutico , Células HeLa , Humanos , Ratones , Orotidina-5'-Fosfato Descarboxilasa/genética , Orotidina-5'-Fosfato Descarboxilasa/metabolismo , Estreptomicina/administración & dosificación , Estreptomicina/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA